Laboratory test based assessment of WHO alcohol risk drinking levels

References

• Connor JP, Haber PS, Hall WD. Alcohol use disorders. Lancet. 2016;387:988–998.
   PubMed Web of Science ®Google Scholar
• Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–2260.
   PubMed Web of Science ®Google Scholar
• Wittchen HU. The burden of mood disorders. Science. 2012;338:15.
   PubMed Web of Science ®Google Scholar
• Hasin DS, Wall M, Witkiewitz K, et al. Change in non-abstinent WHO drinking risk levels and alcohol dependence: a 3 year follow-up study in the US general population. Lancet Psychiatry. 2017;4:469–476.
   PubMed Web of Science ®Google Scholar
• Witkiewitz K, Hallgren KA, Kranzler HR, et al. Clinical validation of reduced alcohol consumption after treatment for alcohol dependence using the World Health Organization risk drinking levels. Alcohol Clin Exp Res. 2017;41:179–186.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Guideline on the development of medicinal products for the treatment of alcohol dependence. London, UK: European Medicines Agency; 2010. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/includes/document/document_detail.jsp?webContentId=WC500074898&mid=WC0b01ac058009a3dc
   Google Scholar
• Food and Drug Administration. Alcoholism: developing drugs for treatment. Silver Spring (MD): Food and Drug Administration; 2015. Available from: https://www.fda.gov/downloads/drugs/…/ucm433618.pdf
   Google Scholar
• Witkiewitz K, Pearson MR, Hallgren KA, et al. Who achieves low risk drinking during alcohol treatment? An analysis of patients in three alcohol clinical trials. Addiction. 2017;112:2112–2121.
   PubMed Web of Science ®Google Scholar
• World Health Organization. International guide for monitoring alcohol consumption and related harm. Geneva, Switzerland: World Health Organization; 2000. Available from: whqlibdoc.who.int/hq/2000/WHO_MSD_MSB_00.4.pdf
   Google Scholar
• Wood AM, Kaptoge S, Butterworth AS, et al. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet. 2018;391:1513–1523.
   PubMed Web of Science ®Google Scholar
• Niemelä O, Niemelä M, Bloigu R, et al. Where should the safe limits of alcohol consumption stand in light of liver enzyme abnormalities in alcohol consumers? PLoS One. 2017;12:e0188574.
   PubMed Web of Science ®Google Scholar
• Danielsson J, Kangastupa P, Laatikainen T, et al. Impacts of common factors of life style on serum liver enzymes. World J Gastroenterol. 2014;20:11743–11752.
   PubMed Web of Science ®Google Scholar
• Kim WR, Flamm SL, Di Bisceglie AM, et al. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology. 2008;47:1363–1370.
   PubMed Web of Science ®Google Scholar
• Lau K, Baumeister SE, Lieb W, et al. The combined effects of alcohol consumption and body mass index on hepatic steatosis in a general population sample of European men and women. Aliment Pharmacol Ther. 2015;41:467–476.
   PubMed Web of Science ®Google Scholar
• Ruhl CE, Everhart JE. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Gastroenterology. 2009;136:477–485.
   PubMed Web of Science ®Google Scholar
• Lee TH, Kim WR, Benson JT, et al. Serum aminotransferase activity and mortality risk in a United States community. Hepatology. 2008;47:880–887.
   PubMed Web of Science ®Google Scholar
• Ruttmann E, Brant LJ, Concin H, et al. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation. 2005;112:2130–2137.
   PubMed Web of Science ®Google Scholar
• Oliveira A, Rodríguez-Artalejo F, Lopes C. Alcohol intake and systemic markers of inflammation–shape of the association according to sex and body mass index. Alcohol Alcohol. 2010;45:119–125.
   PubMed Web of Science ®Google Scholar
• Zheng JS, Sharp SJ, Imamura F, et al. Association between plasma phospholipid saturated fatty acids and metabolic markers of lipid, hepatic, inflammation and glycaemic pathways in eight European countries: a cross-sectional analysis in the EPIC-InterAct study. BMC Med. 2017;15:203.
   PubMed Web of Science ®Google Scholar
• Hao G, Wang Z, Zhang L, et al. Relationship between alcohol consumption and serum lipid profiles among middle-aged population in China: a multiple-center cardiovascular epidemiological study. Angiology. 2015;66:753–758.
   PubMed Web of Science ®Google Scholar
• Wang HJ, Gao B, Zakhari S, et al. Inflammation in alcoholic liver disease. Annu Rev Nutr. 2012;32:343–368.
   PubMed Web of Science ®Google Scholar
• Niemelä O. Biomarker-based approaches for assessing alcohol use disorders. Int J Environ Res Public Health. 2016;13:166.
   PubMed Web of Science ®Google Scholar
• The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol. 1988;41:105–114.
   PubMed Web of Science ®Google Scholar
• Kuulasmaa K, Tolonen H, Cepaitis Z, et al. European health risk monitoring project; 2006; [cited 2018 Apr 5]. Available from: http://www.thl.fi/ehrm/
   Google Scholar
• Kazemi-Shirazi L, Endler G, Winkler S, et al. Gamma glutamyltransferase and long-term survival: is it just the liver? Clin Chem. 2007;53:940–946.
   PubMed Web of Science ®Google Scholar
• Rehm J, Samokhvalov AV, Shield KD. Global burden of alcoholic liver diseases. J Hepatol. 2013;59:160–168.
   PubMed Web of Science ®Google Scholar
• Di Castelnuovo A, Costanzo S, Bagnardi V, et al. Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med. 2006;166:2437–2445.
   PubMed Web of Science ®Google Scholar
• Holmes MV, Dale CE, Zuccolo L, et al. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ. 2014;349:g4164.
   PubMed Web of Science ®Google Scholar
• Klatsky AL. Alcohol and cardiovascular diseases: where do we stand today? J Intern Med. 2015;278:238–250.
   PubMed Web of Science ®Google Scholar
• Sipilä P, Rose RJ, Kaprio J. Drinking and mortality: long-term follow-up of drinking-discordant twin pairs. Addiction. 2016;111:245–254.
   PubMed Web of Science ®Google Scholar
• Stockwell T, Zhao J, Panwar S, et al. Do "moderate" drinkers have reduced mortality risk? A systematic review and meta-analysis of alcohol consumption and all-cause mortality. J Stud Alcohol Drugs. 2016;77:185–198.
   PubMed Web of Science ®Google Scholar
• Topiwala A, Allan CL, Valkanova V, et al. Moderate alcohol consumption as risk factor for adverse brain outcomes and cognitive decline: longitudinal cohort study. BMJ. 2017;357:j2353.
   PubMed Web of Science ®Google Scholar
• Bagnardi V, Rota M, Botteri E, et al. Light alcohol drinking and cancer: a meta-analysis. Ann Oncol. 2013;24:301–308.
   PubMed Web of Science ®Google Scholar
• Cao Y, Willett WC, Rimm EB, et al. Light to moderate intake of alcohol, drinking patterns, and risk of cancer: results from two prospective US cohort studies. BMJ. 2015;351:h4238.
   PubMed Web of Science ®Google Scholar
• Choi YJ, Myung SK, Lee JH. Light alcohol drinking and risk of cancer: a meta-analysis of cohort studies. Cancer Res Treat. 2018;50:474–487.
   PubMed Web of Science ®Google Scholar
• Schwarzinger M, Pollock BG, Hasan OSM, et al. Contribution of alcohol use disorders to the burden of dementia in France 2008–13: a nationwide retrospective cohort study. Lancet Public Health. 2018;3:e124–e132.
   PubMed Web of Science ®Google Scholar
• Catena C, Colussi G, Verheyen ND, et al. Moderate alcohol consumption is associated with left ventricular diastolic dysfunction in nonalcoholic hypertensive patients. Hypertension. 2016;68:1208–1216.
   PubMed Web of Science ®Google Scholar
• McManus DD, Yin X, Gladstone R, et al. Alcohol consumption, left atrial diameter, and atrial fibrillation. J Am Heart Assoc. 2016;5:e004060.
   PubMed Web of Science ®Google Scholar
• Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009;54:2129–2138.
   PubMed Web of Science ®Google Scholar
• Moradi H, Streja E, Kalantar-Zadeh K. Serum high density lipoprotein cholesterol level and risk of death: let's avoid the extremes. J Thorac Dis. 2017;9:4849–4852.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377:1119–1131.
   PubMed Web of Science ®Google Scholar
• Kozakova M, Palombo C, Eng MP, et al. Fatty liver index, gamma-glutamyltransferase, and early carotid plaques. Hepatology. 2012;55:1406–1415.
   PubMed Web of Science ®Google Scholar
• Breitling LP, Raum E, Müller H, et al. Synergism between smoking and alcohol consumption with respect to serum gamma-glutamyltransferase. Hepatology. 2009;49:802–808.
   PubMed Web of Science ®Google Scholar
• Conigrave KM, Degenhardt LJ, Whitfield JB, et al. CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project. Alcohol Clin Exp Res. 2002;26:332–339.
   PubMed Web of Science ®Google Scholar
• Caro AA, Cederbaum AI. Oxidative stress, toxicology, and pharmacology of CYP2E1. Annu Rev Pharmacol Toxicol. 2004;44:27–42.
   PubMed Web of Science ®Google Scholar
• Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology. 1998;114:842–845.
   PubMed Web of Science ®Google Scholar
• Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000;408:239–247.
   PubMed Web of Science ®Google Scholar
• Lee DH, Blomhoff R, Jacobs DR Jr. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res. 2004;38:535–539.
   PubMed Web of Science ®Google Scholar
• Loomba R, Bettencourt R, Barrett-Connor E. Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: the Rancho Bernardo Study. Aliment Pharmacol Ther. 2009;30:1137–1149.
   PubMed Web of Science ®Google Scholar
• Tapper EB, Parikh NH. Mortality due to cirrhosis and liver cancer in the United States, 1999–2016: observational study. BMJ. 2018;362:k2817.
   PubMed Web of Science ®Google Scholar
• Tsukamoto H, Horne W, Kamimura S, et al. Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest. 1995;96:620–630.
   PubMed Web of Science ®Google Scholar
• Liu B, Balkwill A, Reeves G, et al. Body mass index and risk of liver cirrhosis in middle aged UK women: prospective study. BMJ. 2010;340:c912.
   PubMed Web of Science ®Google Scholar
• Tsai J, Ford ES, Zhao G, et al. Co-occurrence of obesity and patterns of alcohol use associated with elevated serum hepatic enzymes in US adults. J Behav Med. 2012;35:200–210.
   PubMed Web of Science ®Google Scholar
• Fraser A, Harris R, Sattar N, et al. Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis. Diabetes Care. 2009;32:741–750.
   PubMed Web of Science ®Google Scholar
• Ghouri N, Preiss D, Sattar N. Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data. Hepatology. 2010;52:1156–1161.
   PubMed Web of Science ®Google Scholar
• Lee DH, Silventoinen K, Hu G, et al. Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women. Eur Heart J. 2006;27:2170–2176.
   PubMed Web of Science ®Google Scholar
• Targher G, Bertolini L, Rodella S, et al. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care. 2007;30:2119–2121.
   PubMed Web of Science ®Google Scholar